Alps Advisors Inc Iveric Bio, Inc. Transaction History

Alps Advisors Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$26.24 - $39.63 $290,844 - $439,258	11,084 Added 12.27%	101,422 $3.99 Million
Q1 2023 May 10, 2023	SELL	$18.67 - $24.56 $9,372 - $12,329	-502 Reduced 0.55%	90,338 $2.2 Million
Q4 2022 Feb 14, 2023	BUY	$17.24 - $23.95 $454,187 - $630,962	26,345 Added 40.85%	90,840 $1.94 Million
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $42,882 - $84,807	-4,562 Reduced 6.61%	64,495 $1.16 Million
Q2 2022 Aug 11, 2022	SELL	$9.12 - $18.9 $454,285 - $941,446	-49,812 Reduced 41.9%	69,057 $664,000
Q1 2022 May 16, 2022	SELL	$12.15 - $16.83 $167,742 - $232,354	-13,806 Reduced 10.41%	118,869 $2 Million
Q4 2021 Feb 09, 2022	BUY	$13.83 - $18.78 $71,902 - $97,637	5,199 Added 4.08%	132,675 $2.22 Million
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $60,787 - $150,465	8,598 Added 7.23%	127,476 $2.07 Million
Q2 2021 Aug 11, 2021	SELL	$5.69 - $7.17 $251,560 - $316,992	-44,211 Reduced 27.11%	118,878 $750,000
Q1 2021 May 07, 2021	BUY	$5.08 - $6.89 $6,680 - $9,060	1,315 Added 0.81%	163,089 $1.01 Million
Q4 2020 Feb 03, 2021	BUY	$5.65 - $7.66 $269,137 - $364,884	47,635 Added 41.73%	161,774 $1.12 Million
Q3 2020 Nov 04, 2020	BUY	$4.01 - $6.29 $182,807 - $286,748	45,588 Added 66.5%	114,139 $644,000
Q2 2020 Aug 05, 2020	BUY	$3.06 - $6.6 $209,766 - $452,436	68,551 New	68,551 $350,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.